Trauma - Tranexamic Acid for Chronic Subdural Hematoma: A Propensity-Matched Analysis

In this episode, we delve into the clinical utility of tranexamic acid in managing chronic subdural hematomas. We examine the findings from a single-center propensity score-matched analysis, published in BMC Neurology in 2026. This study investigated the revision rates and postoperative volume changes in patients undergoing burr hole craniotomy for chronic subdural hematomas, comparing those treated with tranexamic acid adjunctively to surgery alone. The analysis focused on identifying potential benefits or drawbacks of this pharmacological intervention in preventing recurrence and managing hematoma resolution. Tune in to understand the implications for surgical decision-making and patient outcomes. This content is for informational purposes only and does not constitute medical advice.